S.No |
Month |
Title of The Paper |
Page No |
Download |
1 |
December |
PRONIOSOMES – DRUG CARRIER FOR TRANSDEMAL DRUG DELIVERY SYSTEM |
1-9 |
![pdf_img](images/issues-pdf.png) |
2 |
December |
SUSTAINED RELEASE DRUG DELIVERY SYSTEM: AN OVERVIEW |
1-18 |
![pdf_img](images/issues-pdf.png) |
3 |
December |
PRANLUKAST EFFECT ON THE EARLY STAGES OF LIVER DAMAGE IN RATS TREATED WITH CCl4 |
1-14 |
![pdf_img](images/issues-pdf.png) |
4 |
December |
ORODISPERSIBLE TABLETS: DEVELOPMENT, TECHNOLOGIES AND EVALUATION: AN OVERVIEW |
1-20 |
![pdf_img](images/issues-pdf.png) |
5 |
December |
NOVEL SUSTAINED RELEASE DRUG DELIVERY SYSTEM: A REVIEW |
1-18 |
![pdf_img](images/issues-pdf.png) |
6 |
December |
NOVEL APPROCHES FOR ENHANCEMENT OF SOLUBILITY: A REVIEW |
1-15 |
![pdf_img](images/issues-pdf.png) |
7 |
December |
MOUTH DISSOLVING TABLETS, SOLID DISPERSIONS: METHODS TO INCREASE ORAL BIOAVAILABILITY OF POORLY SOLUBLE DRUGS |
1-13 |
![pdf_img](images/issues-pdf.png) |
8 |
December |
HEPATOPROTECTIVE HERBAL MEDICINAL PLANTS: AN REVIEW |
1-8 |
![pdf_img](images/issues-pdf.png) |
9 |
December |
DISSOLUTION TESTING: A QUICK OVERVIEW |
1-16 |
![pdf_img](images/issues-pdf.png) |
10 |
December |
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC METHOD: A REVIEW |
1-13 |
![pdf_img](images/issues-pdf.png) |
11 |
December |
A REVIEW ON SUBLINGUAL TABLETS |
1-14 |
![pdf_img](images/issues-pdf.png) |
12 |
December |
A REVIEW ON FAST DISSOLVING TABLET |
1-14 |
![pdf_img](images/issues-pdf.png) |
13 |
December |
A REVIEW ON “NOVEL CONCEPT OF ORAL FAST DISSOLVING TABLET” |
1-23 |
![pdf_img](images/issues-pdf.png) |
14 |
September |
RECENT TRENDS IN FORMULATION TECHNOLOGY FOR MOUTH DISSOLVING TABLET: AN OVERVIEW |
1-12 |
![pdf_img](images/issues-pdf.png) |
15 |
September |
FORMULATION & EVALUATION OF ORODISPERSIBLE TABLETS OF DIAZEPAM |
1-10 |
![pdf_img](images/issues-pdf.png) |
16 |
September |
DETERMINATION OF TOTAL PHENOLIC CONTENT OF THE STEM BARK OF BAUHINIA VARIEGATA LINN.; AN APPROACH TO STANDARDIZATION |
1-7 |
![pdf_img](images/issues-pdf.png) |
17 |
September |
EFFECT OF PROCESS PARAMETERS ON FORMULATION OF SOLID LIPID NANOPARTICLES OF PROTEASE INHIBITOR, ATAZANAVIR |
1-15 |
![pdf_img](images/issues-pdf.png) |